US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AI Healthcare

753.53

-17.8606-2.32%

Number of Gainers:2

Number of Losers:2

Number of Flat:- -

PE:- -

High:773.90

Open:771.53

Low:750.10

Close:771.39

Volume:12.02M

Turnover:317.47M

Market Cap:24.25B

Float Cap:18.53B

Loading ...

Recursion, Tempus Expand AI and RNA Collaboration Agreements

Tempus AI, Recursion extend data license agreement, enter new license agreement

Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm

THOMSON REUTERS

Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model

THOMSON REUTERS

Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029

THOMSON REUTERS

Recursion Pharmaceuticals - Enters Amendment to Master Agreement with Tempus on Sept 15, 2026 - SEC Filing

THOMSON REUTERS

Recursion Pharmaceuticals - Eliminates Co's Right to Terminate Agreement for Convenience - SEC Filing

THOMSON REUTERS

Recursion Pharmaceuticals - Extends Agreement Term from Five to Six Years - SEC Filing

THOMSON REUTERS

Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target

MT Newswires Live

Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325

Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?

Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak

Recursion’s REC-7735 Trial: Early Precision Oncology Data That Could Move RXRX

Tempus AI rises 14.5%

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg1.tigeractivity.com/stock/BK4611/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4611","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","market":"US","secType":"PLATE","nameCN":"AI Healthcare","latestPrice":753.52924,"timestamp":1790872224726,"preClose":771.38983,"halted":0,"volume":12020699,"delay":0,"changeRate":-0.023154,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-17.860596,"latestTime":"10-01 12:30:24 EDT","open":771.5333,"high":773.896,"low":750.097,"amount":317470062.794797,"amplitude":0.030852,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790884800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.971936,"peRate":-19.013769,"turnoverRate":0.014618,"increases":2,"decrements":2,"flats":0,"marketCap":24251493888,"floatMarketCap":18527082880},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4611\",,,,,undefined,":{"symbol":"BK4611","high":773.896,"amplitude":0.030852,"preClose":771.38983,"low":750.097,"pbRate":"5.971936","latestPrice":753.52924,"volume":12020687,"delay":0,"open":771.5333,"prevYearClose":658.3995,"prevWeekClose":773.7466,"prevMonthClose":771.3898,"prevQuarterClose":771.3898,"fiveDayClose":770.3826,"twentyDayClose":685.4777,"sixtyDayClose":706.715,"secType":"PLATE","market":"US","turnoverRate":0.014618,"peRate":-19.013769,"marketCap":24251493888,"floatMarketCap":18527082880,"timestamp":1790872224142,"nameCN":"AI Healthcare"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4611\",,,,undefined,":{"bkCode":"BK4611","up":2,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4611\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669169875","title":"Recursion, Tempus Expand AI and RNA Collaboration Agreements","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169875","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169875?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:29","pubTimestamp":1789997370,"startTime":"0","endTime":"0","summary":"The latest update is out from Recursion Pharmaceuticals ( ($RXRX) ). On September 15, 2026, Recursion Pharmaceuticals amended its long-term data an...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursion-tempus-expand-ai-and-rna-collaboration-agreements?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RXRX","BK4139","HEAL","TEM","TEMC","ARKG","BK4539","BK4548","LU1861559042.SGD","LU1861558580.USD","BK4121","BK4613","TEMT","BK4611","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669169889","title":"Tempus AI, Recursion extend data license agreement, enter new license agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2669169889","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669169889?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:20","pubTimestamp":1789996814,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) announced an extension of its data license agreement with Recursion Pharmaceuticals (RXRX). Additionally, the two companies have en...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-recursion-extend-data-license-agreement-enter-new-license-agreement-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4609","BK4611","RXRX","BK4613","LU1861558580.USD","ARKG","BK4548","TEMT","BK4139","HEAL","TEM","TEMC","BK4121","LU1861559042.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669666681","title":"Tempus AI, - Recursion Grants Tempus Non-Exclusive Worldwide License to Rna Sequencing Model Txfm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669666681","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669666681?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","BK4539","BK4613","LU1861559042.SGD","BK4548","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","BK4139","LU1861558580.USD","BK4609","TEMT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166574","title":"Tempus and Recursion Extend Existing Data License Agreement and Enter New License Agreement for Recursion’s Rna Foundation Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166574?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["RXRX","LU1861559042.SGD","ARKG","BK4613","BK4611","BK4539","BK4548","TEM","LU1861558580.USD","TEMC","HEAL","BK4609","TEMT","BK4121","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166572","title":"Tempus AI, -Co and Recursion Extend Data Partnership Through November 2029","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166572","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166572?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:14","pubTimestamp":1789996470,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0JP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARKG","LU1861559042.SGD","BK4121","TEMT","TEMC","LU1861558580.USD","BK4548","BK4539","BK4611","BK4613","TEM","HEAL","RXRX","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669663671","title":"Recursion Pharmaceuticals - Enters Amendment to Master Agreement with Tempus on Sept 15, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669663671","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669663671?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4548","BK4611","BK4139","BK4539","BK4609","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166362","title":"Recursion Pharmaceuticals - Eliminates Co's Right to Terminate Agreement for Convenience - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166362","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166362?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4609","BK4539","RXRX","BK4548","BK4139","BK4611"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669166360","title":"Recursion Pharmaceuticals - Extends Agreement Term from Five to Six Years - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2669166360","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669166360?lang=en_us&edition=fundamental","pubTime":"2026-09-21 21:06","pubTimestamp":1789995986,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nFWN45D0BP:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4548","BK4609","BK4611","BK4539","RXRX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669915126","title":"Goldman Sachs Initiates Tempus AI at Neutral With $75 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2669915126","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669915126?lang=en_us&edition=fundamental","pubTime":"2026-09-21 17:20","pubTimestamp":1789982440,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) has an average rating of overweight and mean price target of $67.94, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1861558580.USD","TEMT","BK4611","BK4121","HEAL","TEM","BK4613","LU1861559042.SGD","TEMC","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668971630","title":"Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325","url":"https://stock-news.laohu8.com/highlight/detail?id=2668971630","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668971630?lang=en_us&edition=fundamental","pubTime":"2026-09-19 09:15","pubTimestamp":1789780544,"startTime":"0","endTime":"0","summary":"Tempus AI EVP, Chief Legal Officer Andrew Polovin disposes of 2,951 common shares for $221,325Tempus AI EVP, Chief Legal Officer Andrew Polovin sold 2,951 Class A common shares on Sep. 17, 2026 at USD","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260919:nNDL7xzJg6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Tempus AI EVP, Chief Legal Officer Andrew Polovin Disposes of 2,951 Common Shares for $221,325","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARKG","BK4611","TEMT","TEM","LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","TEMC","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668593947","title":"Tempus AI Stock (TEM) Surges 40% in a Week — Is More Upside Ahead?","url":"https://stock-news.laohu8.com/highlight/detail?id=2668593947","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668593947?lang=en_us&edition=fundamental","pubTime":"2026-09-18 18:15","pubTimestamp":1789726500,"startTime":"0","endTime":"0","summary":"Shares of Tempus AI ($TEM) jumped 15% Thursday, extending their five-day gain to nearly 40%. The rally came after CEO Eric Lefkofsky outlined the c...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/tempus-ai-stock-surges-40-in-a-week-is-more-upside-ahead?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/tempus-ai-stock-surges-40-in-a-week-is-more-upside-ahead?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4611","BK4613","LU1861559042.SGD","LU1861558580.USD","TEMC","BK4121","TEMT","TEM","HEAL","ARKG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668499109","title":"Tempus AI Stock Surges as Revenue Optimism Boosts Winning Streak","url":"https://stock-news.laohu8.com/highlight/detail?id=2668499109","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668499109?lang=en_us&edition=fundamental","pubTime":"2026-09-18 02:34","pubTimestamp":1789670040,"startTime":"0","endTime":"0","summary":"Clarity on how much revenue Tempus AI will bring in through Medicare reimbursements for two of its cancer screenings appeased investors this week as shares surged Thursday.Tempus stock added 15% Thurs","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861558580.USD","LU1861559042.SGD","BK4613","HEAL","TEMT","ARKG","BK4121","TEM","PSNL","BK4611","TEMC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668999378","title":"Recursion’s REC-7735 Trial: Early Precision Oncology Data That Could Move RXRX","url":"https://stock-news.laohu8.com/highlight/detail?id=2668999378","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668999378?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:30","pubTimestamp":1789662635,"startTime":"0","endTime":"0","summary":"Recursion Pharmaceuticals, Inc ($RXRX) announced an update on their ongoing clinical study. Recursion Pharmaceuticals Inc. is running a Phase 1 / 2...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/recursions-rec-7735-trial-early-precision-oncology-data-that-could-move-rxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/recursions-rec-7735-trial-early-precision-oncology-data-that-could-move-rxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4548","BK4139","BK4611","BK4539","RXRX","BK4609"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668599671","title":"Tempus AI rises 14.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2668599671","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668599671?lang=en_us&edition=fundamental","pubTime":"2026-09-18 00:05","pubTimestamp":1789661146,"startTime":"0","endTime":"0","summary":"Tempus AI (TEM) is up 14.5%, or $10.16 to $80.13. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/tempus-ai-rises-14-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/tempus-ai-rises-14-5-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4613","TEM","TEMC","ARKG","BK4121","BK4611","HEAL","LU1861558580.USD","LU1861559042.SGD","TEMT"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":34,"code":"91000000","status":"200"}]}}